Drinking Water Contaminant Candidate List - Draft; Notice of Availability

A resident of Wisconsin is requesting that the EPA investigate whether mifepristone and related compounds are entering waterways and creating risks in local water systems. The commenter argues that these substances should be reviewed as emerging contaminants to ensure community safety and transparency.

An individual is requesting that the EPA investigate whether mifepristone and related compounds are entering waterways and creating risks in wastewater. They argue that the agency should proactively study these residues to ensure community safety and clean water standards.

An individual resident from South Dakota is requesting that the EPA include mifepristone and its related metabolites on the Drinking Water Contaminant Candidate List. They argue that the agency should investigate whether these compounds are entering waterways and pose risks to public health and the environment.

An individual is requesting that the EPA add mifepristone and its related metabolites to the Drinking Water Contaminant Candidate List. They argue that the agency should investigate and monitor these compounds to ensure the safety of community drinking water and environmental health.

An individual resident from Ohio is urging the EPA to include mifepristone and related compounds in the Drinking Water Contaminant Candidate List. They argue that updated monitoring is necessary due to the increase in at-home chemical abortions and that the EPA should investigate whether wastewater treatment systems are effectively removing these substances.

An individual is urging the EPA to include mifepristone and its related metabolites on the Drinking Water Contaminant Candidate List. They argue that the agency should investigate and monitor these compounds to protect public health, the environment, and human dignity.

A resident of Aurelia, Iowa, is requesting that the EPA include mifepristone and its related compounds on the Drinking Water Contaminant Candidate List. The commenter argues that these chemicals should be studied and monitored for potential risks to public health, the environment, and human dignity.

An individual is urging the EPA to include mifepristone and related compounds in the study of drinking water contaminants. They argue that these substances may enter wastewater from clinics and hospitals, potentially posing risks to public health and the environment.

A taxpayer is requesting that the EPA add mifepristone and its related metabolites to the Drinking Water Contaminant Candidate List. The commenter argues that the agency should investigate and monitor these compounds to protect public health and prevent water-quality issues.

An individual is urging the EPA to use its authority under the Safe Drinking Water Act to investigate potential contaminants. They argue that the public deserves transparent testing due to concerns regarding fertility, endocrine disruption, and environmental harm.